Developer docs
API playgroundTry for free, no card

Search company profiles

Azumio

Full company profile

uuid0007ye2

Namestring
Azumio
Legal namestring
Azumio Inc.
Websiteurl
azumio.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Azumio is a privately held, AI-driven digital health company founded in 2011 and headquartered in Redwood City, California. It operates a dual-track business model: a B2C suite of consumer mobile applications distributed through Apple App Store and Google Play, and a B2B enterprise API/SDK business targeting healthcare providers, insurers, employers, and app developers. The consumer portfolio includes Instant Heart Rate, Glucose Buddy, Fitness Buddy, Calorie Mama AI, Argus, Sleep Time, and Meal IQ, with Glucose Buddy described as a top-rated diabetes tracker for over 10 years. The enterprise suite comprises the Food Lens AI food-recognition API (recognizing 5,000+ dishes across 10+ languages), the Azumio 360 unified health-data platform, and the Instant Diabetes Test PPG-based biomarker for Type 2 diabetes trained on data from more than 150,000 people.

The company's core technology relies on proprietary deep-learning and computer-vision models: a PPG-based heart-rate and diabetes-risk pipeline (sequence-to-sequence ML), a food-recognition convolutional model, and a recommendation engine for DNA+ Premium that pairs with Helix sequencing. The company has accumulated over 100 million cumulative downloads, with reported usage of more than 1 billion heart beats, 1 million food photos, and 10 billion steps processed per day, giving it a sizable proprietary health-data asset. The apps are available in more than 150 countries. B2B customers disclosed on its website include Samsung, Prudential, AIA, Stanford, UCSF, WellDoc, Rally, and Prenetics.

Azumio monetizes through three revenue streams: freemium-to-premium subscriptions across its consumer apps, API/SDK and white-label licensing of its AI assets to enterprise customers, and a subscription DNA+ Premium service offered jointly with Helix. The company has raised approximately $3.4 million in total funding across a 2011 Series A (Accel, Felicis, Founders Fund) and 2014 venture debt (Western Technology Investment), and has a small operating team of roughly 11–50 employees. Its active product launches (Instant Diabetes Test, Azumio 360) and DNA+ partnership indicate a strategic emphasis on converting its installed consumer base into an enterprise health-AI licensing business.

Short descriptiontext

Azumio is a Redwood City-based AI digital health company that develops consumer mobile health apps (Instant Heart Rate, Glucose Buddy, Fitness Buddy, Calorie Mama AI, Argus, Sleep Time) and enterprise API/SDK products (Food Lens AI, Azumio 360, Instant Diabetes Test) for healthcare providers, insurers, employers, and app developers worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRedwood City, United States
HQ citystring
Redwood City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health software, mobile fitness apps, AI food recognition, health data APIs, wearable health monitoring
Industry4 codes
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYCRACAQAH
Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYCRACAQAI
Hydration, Nutrition & Metabolic Tracking Devices (Smart Bottles, Breath/Metabolic Analyzers)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYBPAEAHAF
AI/ML Engineering & Model Development Services
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Software Publishers5132
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Digital Health Software
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Azumio Premium Subscription
TypeSubscription Recurring
Description

Premium subscription service offering advanced features across all Azumio apps. Subscriptions are paid in advance (monthly or annual), auto-renew automatically unless cancelled 24 hours before the end of the current period. Special terms apply to Helix DNA+ integrated products.

azumio.com
2API/SDK Licensing
TypeLicensing Royalties
Description

Food Recognition API (Food Lens) and Azumio 360 SDK/APIs offered to enterprise customers for integration into their own applications. Pricing available at dev.caloriemama.ai with free tier available for developers. Commercial licensing for businesses with custom usage-based or subscription pricing.

azumio.com
3Mobile App Distribution
TypeSubscription Recurring
Description

Apps distributed through Apple App Store and Google Play with freemium model. Core features free with premium subscription upgrades. In-app purchases and subscriptions processed through Apple, Google, Amazon, PayPal, and Stripe.

azumio.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Pricing details5 tiers
1Freemium tier with basic heart rate, fitness tracking, and food logging features
ModelFreemiumBilling cadenceMonthly
Notes

Core features free; premium subscription required for advanced features including DNA+ Premium, detailed analytics, and ad-free experience

azumio.com
2Azumio Premium subscription with full feature access
ModelSubscriptionBilling cadenceMonthly
Notes

Paid in advance; auto-renews unless cancelled 24 hours before period end; 14-day withdrawal period after initial subscription; available through App Store, Google Play, Amazon App Store, PayPal, Stripe, and credit card

azumio.com
3Azumio Premium annual subscription with discounted rate
ModelSubscriptionBilling cadenceAnnual
Notes

Annual billing at discounted rate compared to monthly; all premium features included

azumio.com
4Food Lens API developer free tier
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free tier available for developers to try the API; commercial pricing quote-based for production use

azumio.com
5Food Lens API commercial licensing
ModelSubscriptionBilling cadenceAnnual
Notes

Custom pricing based on usage volume and business needs; contact sales for quote

azumio.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 10 records shown
1Glucose Buddy
Description

Top rated all-in-one diabetes tracker for over 10 years

azumio.com
+9 more records
Core offering1 text field

Azumio develops and operates a portfolio of consumer mobile health and fitness applications (including Instant Heart Rate, Glucose Buddy, Fitness Buddy, Calorie Mama AI, Argus, and Sleep Time) and sells enterprise AI/ML API and SDK solutions (Food Lens AI, Azumio 360, Instant Diabetes Test) that enable businesses to embed food recognition, health data tracking, and non-invasive diabetes risk screening into their own products. Its technology stack relies on deep learning, computer vision, and photoplethysmography (PPG) signal processing to deliver health insights via smartphone cameras.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • PPG-based diabetes detection specificity and sensitivity matches Fasting Plasma Glucose clinical method
+4 more records
Product overview1 text field

Azumio is an AI-driven digital health company offering a portfolio of consumer mobile health apps and enterprise API/SDK solutions. The consumer suite includes six core apps: Instant Heart Rate (heart rate monitoring), Glucose Buddy (diabetes tracking), Fitness Buddy (workout tracking), Calorie Mama AI (AI-powered nutrition tracking with food recognition), Argus (community fitness), and Sleep Time (sleep analysis). Business solutions include Food Lens AI (food recognition API recognizing 5,000+ dishes in 15+ languages), Azumio 360 (unified health data API for diet/fitness/sleep tracking), and Instant Diabetes Test (PPG-based diabetes biomarker using machine learning). The company also offers DNA+ Premium combining genetic insights with fitness/nutrition recommendations. With over 100 million downloads and partnerships with Samsung, Stanford, UCSF, and Prudential, Azumio provides both direct-to-consumer apps and B2B APIs for enterprise health applications.

Product and service10 records
1Instant Heart Rate
CategoryConsumer Mobile App
Description

Consumer mobile app that measures heart rate via the smartphone camera using photoplethysmography (PPG), aimed at individuals seeking convenient personal heart rate monitoring without specialized hardware.

2Glucose Buddy
CategoryConsumer Mobile App
Description

Consumer mobile app for tracking blood glucose, medication, meals, and other diabetes management data, targeted at people with diabetes and pre-diabetes.

3Fitness Buddy
CategoryConsumer Mobile App
Description

Consumer mobile app for tracking workouts, exercises, and fitness routines, aimed at individuals pursuing structured exercise programs.

4Calorie Mama AI
CategoryConsumer Mobile App
Description

Consumer mobile app that uses AI food recognition to identify foods from photos and provide calorie and macronutrient information for users logging meals.

5Argus
CategoryConsumer Mobile App
Description

Consumer mobile app that combines activity, step, and sleep tracking with a community-driven fitness experience for individual users.

6Sleep Time
CategoryConsumer Mobile App
Description

Consumer mobile app that analyzes sleep cycles and acts as a smart alarm clock to wake users during light sleep phases.

7Food Lens AI (Food Recognition API/SDK)
CategoryEnterprise API/SDK
Description

AI-powered food recognition API and SDK using deep learning and computer vision to identify dishes and return structured nutrition data, designed for integration by app developers, health platforms, and enterprise customers.

8Azumio 360 API/SDK
CategoryEnterprise API/SDK
Description

Cloud-based health data platform API/SDK that aggregates diet, fitness, sleep, and related health metrics, allowing enterprises (insurers, employers, healthcare providers, app developers) to build white-label health applications and dashboards.

9Instant Diabetes Test (IDT)
CategoryEnterprise API/SDK
Description

Non-invasive digital biomarker API that uses a smartphone camera to capture PPG signals and a sequence-to-sequence ML model to predict the probability of Type 2 diabetes or pre-diabetes, intended for healthcare providers, insurers, and clinical researchers.

10DNA+ Premium
CategorySubscription Service
Description

Subscription service that combines Helix DNA sequencing with Azumio's analytics to deliver personalized workout and nutrition insights based on genetic makeup, available to consumers sequenced by Helix.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Helix is Azumio's genetic testing partner for DNA+ Premium features. Helix sequences user DNA and provides specific genetic markers related to nutrition and fitness to Azumio, which then analyzes genetic variations for personalized wellness recommendations. Users must be sequenced by Helix to access Azumio DNA+ Premium membership features including genetic-based fitness and nutrition insights.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Consumer nutrition tracking app with one of the largest food databases in the world and a subscription model. Directly comparable to Azumio's Calorie Mama AI and broader nutrition/fitness tracking apps in terms of target user, GTM, and content library.

2Noom
TypeDirect peer
Description

Subscription-based digital health app focused on weight management, nutrition logging, and behavior change. Comparable to Azumio in consumer health subscription economics and overlap in calorie tracking and diet coaching use cases.

TypeDirect peer
Description

Digital therapeutics company focused on cardiometabolic chronic disease prevention and management, including diabetes, hypertension, and obesity. Highly comparable to Azumio's Glucose Buddy and IDT in the cardiometabolic RPM and chronic disease management category.

TypeBroad incumbent
Description

Samsung's pre-installed health platform across Galaxy devices with heart rate, sleep, fitness, and nutrition tracking. Both a customer of Azumio's Food Lens AI and a competing platform for the same end users.

5Apple Health
TypeBroad incumbent
Description

OS-level health platform on iOS that aggregates heart rate, sleep, activity, and increasingly nutrition data across native and third-party apps. Represents the most significant platform-level competitive threat to Azumio's standalone consumer health apps.

TypeDirect peer
Description

AI-powered food recognition and nutrition tracking app with B2C and B2B offerings. Comparable to Azumio's Calorie Mama AI and Food Lens in food recognition accuracy and developer API positioning.

TypeDirect peer
Description

Digital therapeutics platform for diabetes and chronic disease management with FDA-cleared products and enterprise payer/provider distribution. Comparable to Azumio's Glucose Buddy, IDT, and Azumio 360 in serving the same healthcare enterprise and chronic disease workflow.

TypeBroad incumbent
Description

Large-scale chronic condition management platform, originally focused on diabetes, now part of Teladoc Health. Comparable to Azumio's Glucose Buddy and IDT in the cardiometabolic chronic disease enterprise space.

TypeDirect peer
Description

Food recognition AI offered via SDK/API to app developers and enterprises. Direct competitor to Azumio's Food Lens AI in computer-vision-based food identification and nutrition analysis as a B2B API.

TypeBroad incumbent
Description

Android-native health and activity platform with deep sensor integration across device OEMs. Competes with Azumio on activity, heart rate, and sleep tracking and is embedded by default on the majority of Azumio's Android distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Azumio

Digital Health Softwareazumio.com

Azumio is a Redwood City-based AI digital health company that develops consumer mobile health apps (Instant Heart Rate, Glucose Buddy, Fitness Buddy, Calorie Mama AI, Argus, Sleep Time) and enterprise API/SDK products (Food Lens AI, Azumio 360, Instant Diabetes Test) for healthcare providers, insurers, employers, and app developers worldwide.

What Azumio does

Azumio is a privately held, AI-driven digital health company founded in 2011 and headquartered in Redwood City, California. It operates a dual-track business model: a B2C suite of consumer mobile applications distributed through Apple App Store and Google Play, and a B2B enterprise API/SDK business targeting healthcare providers, insurers, employers, and app developers. The consumer portfolio includes Instant Heart Rate, Glucose Buddy, Fitness Buddy, Calorie Mama AI, Argus, Sleep Time, and Meal IQ, with Glucose Buddy described as a top-rated diabetes tracker for over 10 years. The enterprise suite comprises the Food Lens AI food-recognition API (recognizing 5,000+ dishes across 10+ languages), the Azumio 360 unified health-data platform, and the Instant Diabetes Test PPG-based biomarker for Type 2 diabetes trained on data from more than 150,000 people.

The company's core technology relies on proprietary deep-learning and computer-vision models: a PPG-based heart-rate and diabetes-risk pipeline (sequence-to-sequence ML), a food-recognition convolutional model, and a recommendation engine for DNA+ Premium that pairs with Helix sequencing. The company has accumulated over 100 million cumulative downloads, with reported usage of more than 1 billion heart beats, 1 million food photos, and 10 billion steps processed per day, giving it a sizable proprietary health-data asset. The apps are available in more than 150 countries. B2B customers disclosed on its website include Samsung, Prudential, AIA, Stanford, UCSF, WellDoc, Rally, and Prenetics.

Azumio monetizes through three revenue streams: freemium-to-premium subscriptions across its consumer apps, API/SDK and white-label licensing of its AI assets to enterprise customers, and a subscription DNA+ Premium service offered jointly with Helix. The company has raised approximately $3.4 million in total funding across a 2011 Series A (Accel, Felicis, Founders Fund) and 2014 venture debt (Western Technology Investment), and has a small operating team of roughly 11–50 employees. Its active product launches (Instant Diabetes Test, Azumio 360) and DNA+ partnership indicate a strategic emphasis on converting its installed consumer base into an enterprise health-AI licensing business.

Azumio firmographics

Firmographics
Name
Azumio
Legal name
Azumio Inc.
Website
https://azumio.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1–10 employees
Short description
Azumio is a Redwood City-based AI digital health company that develops consumer mobile health apps (Instant Heart Rate, Glucose Buddy, Fitness Buddy, Calorie Mama AI, Argus, Sleep Time) and enterprise API/SDK products (Food Lens AI, Azumio 360, Instant Diabetes Test) for healthcare providers, insurers, employers, and app developers worldwide.
Ownership category
akta.pro rank

Azumio industry classification

Industry
Product category
Digital Health Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Software Publishers (5132)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYCRACAQAH
Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYCRACAQAI
Hydration, Nutrition & Metabolic Tracking Devices (Smart Bottles, Breath/Metabolic Analyzers)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYBPAEAHAF
AI/ML Engineering & Model Development Services

Keywords

  • Digital health software
  • Mobile fitness apps
  • AI food recognition
  • Health data APIs
  • Wearable health monitoring

Where Azumio is headquartered

Location

Headquarters

HQ city
Redwood City
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Azumio business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Azumio Premium Subscription: Premium subscription service offering advanced features across all Azumio apps. Subscriptions are paid in advance (monthly or annual), auto-renew automatically unless cancelled 24 hours before the end of the current period. Special terms apply to Helix DNA+ integrated products.
  2. API/SDK Licensing: Food Recognition API (Food Lens) and Azumio 360 SDK/APIs offered to enterprise customers for integration into their own applications. Pricing available at dev.caloriemama.ai with free tier available for developers. Commercial licensing for businesses with custom usage-based or subscription pricing.
  3. Mobile App Distribution: Apps distributed through Apple App Store and Google Play with freemium model. Core features free with premium subscription upgrades. In-app purchases and subscriptions processed through Apple, Google, Amazon, PayPal, and Stripe.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFreemium tier with basic heart rate, fitness tracking, and food logging features
SubscriptionMonthlyAzumio Premium subscription with full feature access
SubscriptionAnnualAzumio Premium annual subscription with discounted rate
FreemiumPay-as-you-goFood Lens API developer free tier
SubscriptionAnnualFood Lens API commercial licensing

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Azumio product offering

Product offering

Core offering

Azumio develops and operates a portfolio of consumer mobile health and fitness applications (including Instant Heart Rate, Glucose Buddy, Fitness Buddy, Calorie Mama AI, Argus, and Sleep Time) and sells enterprise AI/ML API and SDK solutions (Food Lens AI, Azumio 360, Instant Diabetes Test) that enable businesses to embed food recognition, health data tracking, and non-invasive diabetes risk screening into their own products. Its technology stack relies on deep learning, computer vision, and photoplethysmography (PPG) signal processing to deliver health insights via smartphone cameras.

Product overview

Azumio is an AI-driven digital health company offering a portfolio of consumer mobile health apps and enterprise API/SDK solutions. The consumer suite includes six core apps: Instant Heart Rate (heart rate monitoring), Glucose Buddy (diabetes tracking), Fitness Buddy (workout tracking), Calorie Mama AI (AI-powered nutrition tracking with food recognition), Argus (community fitness), and Sleep Time (sleep analysis). Business solutions include Food Lens AI (food recognition API recognizing 5,000+ dishes in 15+ languages), Azumio 360 (unified health data API for diet/fitness/sleep tracking), and Instant Diabetes Test (PPG-based diabetes biomarker using machine learning). The company also offers DNA+ Premium combining genetic insights with fitness/nutrition recommendations. With over 100 million downloads and partnerships with Samsung, Stanford, UCSF, and Prudential, Azumio provides both direct-to-consumer apps and B2B APIs for enterprise health applications.

Differentiator

Problem solved

Functional benefit

Brands

  • Glucose Buddy: Top rated all-in-one diabetes tracker for over 10 years
  • Calorie Mama AI
  • Argus
  • Sleep Time
  • Instant Heart Rate
  • Fitness Buddy
  • Food Lens AI
  • Azumio 360
  • Instant Diabetes Test
  • Meal IQ

Products and services

  • Instant Heart Rate Consumer mobile app that measures heart rate via the smartphone camera using photoplethysmography (PPG), aimed at individuals seeking convenient personal heart rate monitoring without specialized hardware.
  • Glucose Buddy Consumer mobile app for tracking blood glucose, medication, meals, and other diabetes management data, targeted at people with diabetes and pre-diabetes.
  • Fitness Buddy Consumer mobile app for tracking workouts, exercises, and fitness routines, aimed at individuals pursuing structured exercise programs.
  • Calorie Mama AI Consumer mobile app that uses AI food recognition to identify foods from photos and provide calorie and macronutrient information for users logging meals.
  • Argus Consumer mobile app that combines activity, step, and sleep tracking with a community-driven fitness experience for individual users.
  • Sleep Time Consumer mobile app that analyzes sleep cycles and acts as a smart alarm clock to wake users during light sleep phases.
  • Food Lens AI (Food Recognition API/SDK) AI-powered food recognition API and SDK using deep learning and computer vision to identify dishes and return structured nutrition data, designed for integration by app developers, health platforms, and enterprise customers.
  • Azumio 360 API/SDK Cloud-based health data platform API/SDK that aggregates diet, fitness, sleep, and related health metrics, allowing enterprises (insurers, employers, healthcare providers, app developers) to build white-label health applications and dashboards.
  • Instant Diabetes Test (IDT) Non-invasive digital biomarker API that uses a smartphone camera to capture PPG signals and a sequence-to-sequence ML model to predict the probability of Type 2 diabetes or pre-diabetes, intended for healthcare providers, insurers, and clinical researchers.
  • DNA+ Premium Subscription service that combines Helix DNA sequencing with Azumio's analytics to deliver personalized workout and nutrition insights based on genetic makeup, available to consumers sequenced by Helix.

Quantifiable outcome

  • PPG-based diabetes detection specificity and sensitivity matches Fasting Plasma Glucose clinical method
  • +4 more outcomes

Companies that use Azumio

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Azumio technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Azumio partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • HelixcoreStrategic or Co-development PartnerHelix is Azumio's genetic testing partner for DNA+ Premium features. Helix sequences user DNA and provides specific genetic markers related to nutrition and fitness to Azumio, which then analyzes genetic variations for personalized wellness recommendations. Users must be sequenced by Helix to access Azumio DNA+ Premium membership features including genetic-based fitness and nutrition insights.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Azumio competitors and assessment

Company assessment

Direct peers

  • MyFitnessPal: Consumer nutrition tracking app with one of the largest food databases in the world and a subscription model. Directly comparable to Azumio's Calorie Mama AI and broader nutrition/fitness tracking apps in terms of target user, GTM, and content library.
  • Noom: Subscription-based digital health app focused on weight management, nutrition logging, and behavior change. Comparable to Azumio in consumer health subscription economics and overlap in calorie tracking and diet coaching use cases.
  • Omada Health: Digital therapeutics company focused on cardiometabolic chronic disease prevention and management, including diabetes, hypertension, and obesity. Highly comparable to Azumio's Glucose Buddy and IDT in the cardiometabolic RPM and chronic disease management category.
  • Foodvisor: AI-powered food recognition and nutrition tracking app with B2C and B2B offerings. Comparable to Azumio's Calorie Mama AI and Food Lens in food recognition accuracy and developer API positioning.
  • WellDoc: Digital therapeutics platform for diabetes and chronic disease management with FDA-cleared products and enterprise payer/provider distribution. Comparable to Azumio's Glucose Buddy, IDT, and Azumio 360 in serving the same healthcare enterprise and chronic disease workflow.
  • Passio AI: Food recognition AI offered via SDK/API to app developers and enterprises. Direct competitor to Azumio's Food Lens AI in computer-vision-based food identification and nutrition analysis as a B2B API.

Broad incumbents

  • Samsung Health: Samsung's pre-installed health platform across Galaxy devices with heart rate, sleep, fitness, and nutrition tracking. Both a customer of Azumio's Food Lens AI and a competing platform for the same end users.
  • Apple Health: OS-level health platform on iOS that aggregates heart rate, sleep, activity, and increasingly nutrition data across native and third-party apps. Represents the most significant platform-level competitive threat to Azumio's standalone consumer health apps.
  • Livongo (Teladoc Health): Large-scale chronic condition management platform, originally focused on diabetes, now part of Teladoc Health. Comparable to Azumio's Glucose Buddy and IDT in the cardiometabolic chronic disease enterprise space.
  • Google Fit: Android-native health and activity platform with deep sensor integration across device OEMs. Competes with Azumio on activity, heart rate, and sleep tracking and is embedded by default on the majority of Azumio's Android distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Azumio social profiles

Digital presence

Azumio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Azumio leadership team

Management profile

Number of profiles

Profiles4 records

Azumio funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Azumio M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Azumio

What does Azumio do?

Azumio develops and operates a portfolio of consumer mobile health and fitness applications (including Instant Heart Rate, Glucose Buddy, Fitness Buddy, Calorie Mama AI, Argus, and Sleep Time) and sells enterprise AI/ML API and SDK solutions (Food Lens AI, Azumio 360, Instant Diabetes Test) that enable businesses to embed food recognition, health data tracking, and non-invasive diabetes risk screening into their own products. Its technology stack relies on deep learning, computer vision, and photoplethysmography (PPG) signal processing to deliver health insights via smartphone cameras.

Is Azumio a public or private company?

Azumio is a private company. It is classified as venture growth investor backed and is currently operating.

When was Azumio founded?

Azumio was founded in 2011. It employs 1 to 10 people.

Where is Azumio based?

Azumio is headquartered in Redwood City, United States, in the North America region.

How does Azumio make money?

Three revenue lines are on record. Azumio Premium Subscription is the primary driver. The others are API/SDK Licensing and mobile App Distribution.

Who are Azumio's main competitors?

Direct peers on record are MyFitnessPal, Noom, Omada Health, Foodvisor, WellDoc and Passio AI. Broad incumbents are Samsung Health, Apple Health, Livongo (Teladoc Health) and Google Fit.

Does Azumio have an API?

Yes. Azumio offers Food Recognition API (Food Lens) for food identification, nutrition analysis, and categorization using deep learning AI. The API supports recognition of over 5,000 dishes and foods globally, translated in over 10 languages. Available via API and SDK integration with customization options for business and application needs. Documentation available at dev.caloriemama.ai with pricing at dev.caloriemama.ai. Developer documentation is at dev.caloriemama.ai/docs.

What industry is Azumio in?

Azumio's product category is Digital Health Software. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of CRACAQAH, Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireExercise and Weight Loss Apps Global Strategic Business Report 2026-2030, Competitive Analysis of Aaptiv, ASICS, Azumio, Caliber, Fitbod, Google, HealthifyMe Wellness, Jefit, Jevo, Kic AppResearchAndMarkets.com published a global strategic business report on the exercise and weight loss apps market, estimating the market at US$840.3 million in 2025 and projecting it to reach US$2.6 billion by 2032, growing at a compound annual growth rate of 17.4%. The report analyzes market trends, drivers, competitive landscape, and regional forecasts across platforms including iOS and Android, covering key markets such as the United States, China, Japan, and Canada. Growth is attributed to technological advancements, wearable device integration, increasing health awareness, and the proliferation of smartphones driving adoption of fitness and dietary management tools.Coherent Market InsightsSports And Fitness Apps Market Trends & Forecast, 2026-2033The global sports and fitness apps market is valued at USD 15,629.6 million in 2026 and is projected to reach USD 94,948.3 million by 2033, growing at a CAGR of 29.4%, driven by rising health awareness, smartphone penetration, and AI integration in fitness solutions. North America leads with 26.10% market share in 2026, while Asia Pacific emerges as the fastest-growing region at 23.2%, with India showing particularly strong adoption trends. Key industry players including ASICS Digital, Fitbit, Freeletics, Garmin, and Azumio are positioned to benefit from market expansion, though data privacy concerns and premium subscription costs remain potential growth restraints.openPR.comJapan Digital Therapeutics for Diabetes Market to Reach US$ 136.44 Million by 2033, Growing at a CAGR of 10.4% During 2025-2033 | Key Players: Welldoc, Omada Health, Glooko, Azumio, Abbott LaboratorieThe Japan digital therapeutics for diabetes market is projected to grow from US$ 56.59 million in 2024 to US$ 136.44 million by 2033, driven by rising diabetes prevalence and the integration of AI-powered mobile apps and wearable devices. Key industry developments include strategic acquisitions by companies such as Omron Healthcare and CureApp, Inc., alongside broader collaborations between healthcare providers and technology firms to enhance patient adherence and glycemic control.GlobeNewswire$25.8 Billion Fitness Apps Landscape Analysis, 2025-2030, Featuring Aaptiv, Azumio, Google, MyFitnessPal, Nike, Noom, Polar Electro, Strava, Wahoo FitnessA ResearchAndMarkets.com market research report projects the global fitness apps market will grow from $12.1 billion in 2024 to $25.8 billion by 2030, representing a compound annual growth rate of 13.5%. The report identifies key industry players including Google, Nike, MyFitnessPal, Strava, and others, while highlighting growth drivers such as AI-driven personalization, wearable device integration, and rising health awareness following the COVID-19 pandemic.openPR.comUnited States 7MM Digital Therapeutics for Diabetes Market: FDA Clearance & Clinical Validation Mandate By 2025-2033 | Major Companies - Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc.The 7MM digital therapeutics for diabetes market reached US$961.09 million in 2024 and is projected to reach US$2,578.46 million by 2033, a CAGR of 11.7%. The diabetes segment holds the dominant share, with India's market estimated at USD219.41 million in 2025. Growth is driven by rising diabetes prevalence and AI-based analytics.openPR.comDigital Therapeutics for Diabetes Market is projected to reach US$ 5.3 billion by 2033 | Welldoc Inc, Omada Health Inc, Glooko Inc, Azumio Inc, mySugr GmbH, Dexcom Inc, Health2Sync, iHealth Labs IncThe digital therapeutics for diabetes market was valued at US$ 1.6 billion in 2023 and is projected to reach US$ 5.3 billion by 2033, a CAGR of 12.9%. Growth is driven by rising diabetes prevalence, with 536.6 million adults affected in 2021. Key players include Welldoc, Omada Health, and Dexcom.openPR.com7MM Diabetes Digital Therapeutics Market: Trends & Innovations 2025-2033 | Most Leading Companies - Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories, mySugr GmbHThe 7MM diabetes digital therapeutics market reached US$961.09 million in 2024 and is projected to reach US$2,578.46 million by 2033, a CAGR of 11.7%. Key players include Welldoc, Omada Health, and Abbott, with recent launches like ByramConnect and Eversense 365.GlobeNewswireFitness Apps Global Industry Report 2025, with Profiles of 60+ Key Market Players including Aaptiv, Azumio, MyfitnessPal, Nike, Noom, Polar Electro, Strava, Wahoo Fitness and MoreThe global fitness apps market is projected to grow from US$12.1 billion in 2024 to US$25.8 billion by 2030, driven by increasing consumer demand for personalized, flexible, and holistic health solutions. The market growth is supported by technological developments, expanding smartphone and wearable device adoption, and shifts towards preventive healthcare.